Literature DB >> 24330128

Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol.

Dainius A Balis1, Cindy Tong, Gary Meininger.   

Abstract

Entities:  

Keywords:  1,5-anhydroglucitol; GlycoMark®; canagliflozin; sodium-glucose cotransporter 2 inhibitor

Mesh:

Substances:

Year:  2014        PMID: 24330128     DOI: 10.1111/1753-0407.12116

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


× No keyword cloud information.
  9 in total

Review 1.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 2.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

3.  Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.

Authors:  Motoshi Ouchi; Kenzo Oba; Kohei Kaku; Hideki Suganami; Akihiro Yoshida; Yasunori Fukunaka; Promsuk Jutabha; Asuka Morita; Naoyuki Otani; Keitaro Hayashi; Tomoe Fujita; Tatsuya Suzuki; Masahiro Yasutake; Naohiko Anzai
Journal:  Diabetes Obes Metab       Date:  2018-01-08       Impact factor: 6.577

4.  Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.

Authors:  Maria Veiga-da-Cunha; Nathalie Chevalier; Xavier Stephenne; Jean-Philippe Defour; Nicole Paczia; Alina Ferster; Younes Achouri; Joseph P Dewulf; Carole L Linster; Guido T Bommer; Emile Van Schaftingen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-09       Impact factor: 11.205

5.  SGLT-1-specific inhibition ameliorates renal failure and alters the gut microbial community in mice with adenine-induced renal failure.

Authors:  Hsin-Jung Ho; Koichi Kikuchi; Daiki Oikawa; Shun Watanabe; Yoshitomi Kanemitsu; Daisuke Saigusa; Ryota Kujirai; Wakako Ikeda-Ohtsubo; Mariko Ichijo; Yukako Akiyama; Yuichi Aoki; Eikan Mishima; Yoshiaki Ogata; Yoshitsugu Oikawa; Tetsuro Matsuhashi; Takafumi Toyohara; Chitose Suzuki; Takehiro Suzuki; Nariyasu Mano; Yoshiteru Kagawa; Yuji Owada; Takane Katayama; Toru Nakayama; Yoshihisa Tomioka; Takaaki Abe
Journal:  Physiol Rep       Date:  2021-12

Review 6.  Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus.

Authors:  Margarita Ortiz-Martínez; Mirna González-González; Alexandro J Martagón; Victoria Hlavinka; Richard C Willson; Marco Rito-Palomares
Journal:  Curr Diab Rep       Date:  2022-03-10       Impact factor: 5.430

7.  The clinical impact of serum 1,5-anhydro-D-glucitol levels on coronary artery calcification and adverse outcomes assessed by coronary optical coherence tomography in diabetic patients.

Authors:  Hsin-I Teng; Hsiang-Yao Chen; Chuan-Tsai Tsai; Wei-Chieh Huang; Ying-Ying Chen; Chien-Hung Hsueh; William K Hau; Tse-Min Lu
Journal:  Front Cardiovasc Med       Date:  2022-08-30

Review 8.  Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus.

Authors:  Curtis Triplitt; Susan Cornell
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2015-10-18

Review 9.  Novel biomarkers for prediabetes, diabetes, and associated complications.

Authors:  Brenda Dorcely; Karin Katz; Ram Jagannathan; Stephanie S Chiang; Babajide Oluwadare; Ira J Goldberg; Michael Bergman
Journal:  Diabetes Metab Syndr Obes       Date:  2017-08-14       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.